Measuring the entire endocrine panel is complex, expensive, and can introduce a lot of noise
They are part of a rapidly expanding class of incretin-based medications that includes several other notable compounds
Frequency: Once a week, subcutaneous holding the same day and time each week aids consistency
[2026]" as a comparison page where the details that matter most are access, cost, clinical fit, and what a licensed clinician should confirm
Of course, regulatory approval will hinge on demonstrating not just efficacy but long-term safety (perhaps via an outcomes trial to show no increase in cardiovascular events, similar to requirements for diabetes drugs)
received funding from Herlev and Gentofte University Hospital